Literature DB >> 1379197

Crossing three membranes. Channel formation by aerolysin.

J T Buckley1.   

Abstract

Aerolysin is a channel-forming toxin responsible for the pathogenicity of Aeromonas hydrophila. It crosses the inner and outer membranes of the bacteria in separate steps and is released as a 52-kDa inactive protoxin which is activated by proteolytic removal of approximately 40 amino acids from the C terminus. The toxin binds to the erythrocyte transmembrane protein glycophorin and oligomerizes before inserting into the membrane, producing a voltage gated, anion selective channel about 1 nm in diameter. Remarkably, proaerolysin appears to be dimeric, whereas the oligomer is a heptamer. Using chemical modification and site-directed mutagenesis, we have identified some of the regions of the molecule which appear to be involved in secretion and in channel formation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379197     DOI: 10.1016/0014-5793(92)80896-o

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Live imaging assay for assessing the roles of Ca2+ and sphingomyelinase in the repair of pore-forming toxin wounds.

Authors:  Christina Tam; Andrew R Flannery; Norma Andrews
Journal:  J Vis Exp       Date:  2013-08-25       Impact factor: 1.355

2.  Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Authors:  Samuel R Denmeade; Blair Egerdie; Gary Steinhoff; Rosemina Merchant; Ralph Abi-Habib; Peter Pommerville
Journal:  Eur Urol       Date:  2010-11-24       Impact factor: 20.096

3.  The deletion of several amino acid stretches of Escherichia coli alpha-hemolysin (HlyA) suggests that the channel-forming domain contains beta-strands.

Authors:  Roland Benz; Elke Maier; Susanne Bauer; Albrecht Ludwig
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.